Early Day Motion·EDM 28

NORPLANT CONTRACEPTIVE IMPLANTS

7 December 19952 Signatures

Motion Text

leave out from 'House' to end and add 'notes that Norplant has been approved for use in Finland since 1983, and in over 40 countries, including the USA; further notes that since then it has been used by over one million American women; recognises the concerns of the Norplant Action Group about information for potential users of the contraceptive; but expresses deep concern at the interpretation in the BBC2 Horizon programme on 6th November relating to Norplant clinical and Bangladesh preintroduction trials, and to the unfounded allegations of a link between Norplant and the syndrome idiopathic intracranial hypertension; welcomes assurances from WHO that the allegations in the Horizon programme of lacing of tetanus vaccine with a contraceptive are totally false; further notes that such allegations could damage international programmes to reduce neonatal tetanus, a major cause of infant mortality in many countries; deplores Horizon's linking of quinacrine, an inadequately tested contraceptive, with Norplant; welcomes the development and introduction of comprehensively tested and researched methods of contraception; but calls for strict enforcement and improvement of training for doctors inserting and removing Norplant contraceptives in Britain and comprehensive monitoring and follow-up of women using this method of contraception.'.